Ancalima Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.00 Cr
as on 16-11-2024
- Company Age 36 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.84 Cr
as on 16-11-2024
- Satisfied Charges ₹ 11.10 Cr
as on 16-11-2024
- Revenue -3.38%
(FY 2023)
- Profit -87.70%
(FY 2023)
- Ebitda 67.89%
(FY 2023)
- Net Worth -0.20%
(FY 2023)
- Total Assets 7.41%
(FY 2023)
About Ancalima Lifesciences
The Corporate was formerly known as Uni Sule Laboratories Pvt Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹5.84 Cr. The company has closed loans amounting to ₹11.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajeev Garg, Sakshi Garg, and Sandeep Sharma serve as directors at the Company.
- CIN/LLPIN
U52110DL1988PLC031451
- Company No.
031451
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
02 May 1988
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ancalima Lifesciences Limited offer?
Ancalima Lifesciences Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Face Cream, Skin Care Cosmetics, Face Wash, Neem Face Wash, Anti Infective Drugs & Medicines, Antibacterial Drugs, Cardiovascular Drugs & Medication, Cardiac Drugs, TB, Tumor & Cancer Drugs.
Who are the key members and board of directors at Ancalima Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeev Garg  | Director | 15-Feb-1996 | Current |
| Sakshi Garg | Director | 11-Jul-2024 | Current |
| Sandeep Sharma | Director | 01-Apr-2019 | Current |
Financial Performance of Ancalima Lifesciences.
Ancalima Lifesciences Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.38% decrease. The company also saw a substantial fall in profitability, with a 87.7% decrease in profit. The company's net worth dipped by a decrease of 0.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ancalima Lifesciences?
In 2023, Ancalima Lifesciences had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shresva Global Cosmed Private LimitedActive 76 years 10 monthsRajeev Garg and Sakshi Garg are mutual person
- Tejosh E-Commerce Private LimitedActive 9 years 3 months
Rajeev Garg and Sakshi Garg are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 09 May 2024 | ₹1.58 M | Open |
Canara Bank Creation Date: 28 Sep 2022 | ₹5.68 Cr | Open |
Others Creation Date: 01 Feb 2022 | ₹3.17 M | Satisfied |
How Many Employees Work at Ancalima Lifesciences?
Ancalima Lifesciences has a workforce of 51 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ancalima Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ancalima Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
